Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$0.77 - $4.91 $11,704 - $74,632
-15,200 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$2.18 - $4.66 $10,900 - $23,300
-5,000 Reduced 24.75%
15,200 $70,000
Q3 2020

Nov 17, 2020

BUY
$0.67 - $1.4 $13,534 - $28,280
20,200 New
20,200 $28,000
Q1 2020

May 14, 2020

SELL
$0.39 - $1.03 $5,109 - $13,493
-13,100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$0.89 - $1.5 $32,841 - $55,350
-36,900 Reduced 73.8%
13,100 $14,000
Q3 2019

Nov 13, 2019

BUY
$1.04 - $1.51 $52,000 - $75,500
50,000 New
50,000 $59,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.